Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study

Clinical trial NCT02748694 · COMPLETED

Trial details

NCT number: NCT02748694
Sponsor: Neurocrine Biosciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Schizophrenia

Start date: 2016-05-09
Primary completion: 2019-09-22
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.